scispace - formally typeset
J

J. M. de la Fuente

Researcher at University of Zaragoza

Publications -  9
Citations -  401

J. M. de la Fuente is an academic researcher from University of Zaragoza. The author has contributed to research in topics: Nanocarriers & Fibroin. The author has an hindex of 8, co-authored 9 publications receiving 350 citations.

Papers
More filters
Journal ArticleDOI

Notice of Violation of IEEE Publication Principles Nuclear Localization of HIV-1 Tat Functionalized Gold Nanoparticles

TL;DR: Water soluble, biocompatible gold nanoparticles of differing size functionalized with the HIV-1 tat PTD are developed with the aim of producing nuclear targeting agents and results demonstrate successful nanoparticle transfer across the plasma membrane.
Journal ArticleDOI

Designing novel nano-immunoassays: antibody orientation versus sensitivity

TL;DR: The importance of nanoparticle functionalization for the improvement of sensitivity for a lateral-flow immunoassay is reported and it is found that immobilization of IgG anti-hCG through its polysaccharide moieties on MNPs allows more successful recognition of the hCG hormone.
Journal ArticleDOI

Functionalized Fe₃O₄@Au superparamagnetic nanoparticles: in vitro bioactivity.

TL;DR: It was demonstrated that nanoparticles clearly interacted with the cells, showing a higher level of accumulation in the cells for glucose conjugated nanoparticles, which enhances the superparamagnetic behaviour observed above 10-15 K in this kind of nanoparticle.
Journal ArticleDOI

Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats.

TL;DR: In this article, the interaction of the silk fibroin nanoparticles (SFNs) with the injured intestinal tissue by functionalizing them with the peptide motif RGD (arginine-glycine-aspartic acid) and to evaluate the intestinal anti-inflammatory properties of these RGD-functionalized silk fiber-SFNs in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis.
Journal ArticleDOI

New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules

TL;DR: The promising behaviour of drug-loaded nanocarriers will hopefully lead to a reduction of the administered doses of a quite dangerous drug as bedaquiline, tuning its biodistribution and so decreasing its adverse effects, finally allowing its use in a higher number of patients.